ClinicalTrials.govpublic full text
Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome
leukemia, myelodysplastic syndromes, myelodysplastic/myeloproliferative diseases, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, chronic myelomonocytic leukemia, de novo myelodysplastic syndromes, previously treated myelodysplastic syndromes, secondary myelodysplastic syndromes, refractory cytopenia with multilineage dysplasia, atypical chronic myeloid leukemia, myelodysplastic/myeloproliferative disease, unclassifiable
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 863668
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.